HUP0004813A2 - Compositions and methods for treating respiratory disorders - Google Patents
Compositions and methods for treating respiratory disordersInfo
- Publication number
- HUP0004813A2 HUP0004813A2 HU0004813A HUP0004813A HUP0004813A2 HU P0004813 A2 HUP0004813 A2 HU P0004813A2 HU 0004813 A HU0004813 A HU 0004813A HU P0004813 A HUP0004813 A HU P0004813A HU P0004813 A2 HUP0004813 A2 HU P0004813A2
- Authority
- HU
- Hungary
- Prior art keywords
- compositions
- methods
- respiratory disorders
- treating respiratory
- related compound
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title 1
- 208000023504 respiratory system disease Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- ZKLPARSLTMPFCP-UHFFFAOYSA-N Cetirizine Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-UHFFFAOYSA-N 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- 229960001803 cetirizine Drugs 0.000 abstract 1
- 206010022000 influenza Diseases 0.000 abstract 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 abstract 1
- 229960002009 naproxen Drugs 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A találmány tárgyát meghűlés, meghűlésszerű tünetek, allergia, orrmelléküreg és/vagy influenza tünetek javított kezelésére, ellátásáravagy enyhítésére szolgáló készítmények és eljárások képezik. Azeljárás során naproxent vagy azzal rokon vegyületet cetirizinnel vagyazzal rokon vegyülettel együtt tartalmazó készítmény biztonságos éshatásos mennyiségét adják be. ÓThe subject of the invention are preparations and procedures for the improved treatment, care or relief of colds, cold-like symptoms, allergy, sinus and/or flu symptoms. In this procedure, a safe and effective amount of a preparation containing naproxen or a related compound together with cetirizine or a related compound is administered. HE
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93403397A | 1997-09-19 | 1997-09-19 | |
| PCT/IB1998/001339 WO1999015173A1 (en) | 1997-09-19 | 1998-08-28 | Compositions and methods for treating respiratory disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0004813A2 true HUP0004813A2 (en) | 2001-08-28 |
Family
ID=25464848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0004813A HUP0004813A2 (en) | 1997-09-19 | 1998-08-28 | Compositions and methods for treating respiratory disorders |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1014983A1 (en) |
| JP (1) | JP2001517626A (en) |
| KR (1) | KR20010024187A (en) |
| CN (1) | CN1278728A (en) |
| AU (1) | AU8744398A (en) |
| BR (1) | BR9812660A (en) |
| CA (1) | CA2304005A1 (en) |
| CO (1) | CO5011084A1 (en) |
| HU (1) | HUP0004813A2 (en) |
| NO (1) | NO20001412D0 (en) |
| PE (1) | PE118999A1 (en) |
| WO (1) | WO1999015173A1 (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004508324A (en) * | 2000-09-08 | 2004-03-18 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | Prevent acute sinusitis and sinus attacks |
| WO2003000264A1 (en) * | 2001-06-20 | 2003-01-03 | Schering Corporation | Antihistamines for the treatment of nasal congestion and nasal obstruction |
| US6863901B2 (en) | 2001-11-30 | 2005-03-08 | Collegium Pharmaceutical, Inc. | Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration |
| US6827946B2 (en) * | 2001-12-05 | 2004-12-07 | Collegium Pharmaceutical, Inc. | Compositions containing both sedative and non-sedative antihistamines |
| US7166641B2 (en) * | 2002-10-02 | 2007-01-23 | Yung Shin Pharmaceutical Industrial Co., Ltd. | Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same |
| TWI313598B (en) | 2002-12-18 | 2009-08-21 | Wyeth Corp | Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines |
| US20050192355A1 (en) * | 2004-02-17 | 2005-09-01 | Wyeth | Compositions of non-steroidal anti-inflammatory drugs and decongestants or anti-histamines |
| CN101073563B (en) * | 2007-02-07 | 2010-10-06 | 西安利君制药有限责任公司 | Chiral composition containing dextrothyroxine buprofenli and levomethadyl cysteliqin and its double slow-releasing tablet |
| GB0719518D0 (en) * | 2007-10-05 | 2007-11-14 | Therapeutics Ltd E | Therapy |
| US8252330B2 (en) | 2009-01-05 | 2012-08-28 | Mcneil-Ppc, Inc. | Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen |
| US8377475B2 (en) | 2009-01-05 | 2013-02-19 | Mcneil-Ppc, Inc. | Tablet containing cetirizine, pseudoephedrine, and naproxen containing a barrier layer |
| CA2748783A1 (en) | 2009-01-05 | 2010-07-08 | Mcneil-Ppc, Inc. | Three layer tablet containing cetirizine, pseudoephedrine, and naproxen |
| GB0905954D0 (en) * | 2009-04-06 | 2009-05-20 | E Therapeutics Plc | Treatment of exacerbations of asthma |
| CN103446587A (en) * | 2011-12-28 | 2013-12-18 | 汪明 | Application of mastocyte inhibitor in preparation of medicine for resisting influenza virus infection |
| CN103251590B (en) * | 2013-05-13 | 2014-12-17 | 中国科学院武汉病毒研究所 | Application of doxylamine succinate in preparing drug for treating or preventing influenza virus |
| NZ735777A (en) | 2015-03-26 | 2023-03-31 | Jacqueline M Iversen | Methods and compositions to inhibit symptoms associated with veisalgia |
| CN109464670B (en) * | 2017-09-08 | 2022-08-02 | 中国科学院微生物研究所 | Key amino acid site for regulating and controlling nucleoprotein nuclear production of influenza A virus and influenza B virus and application of key amino acid site as anti-influenza virus drug target |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4871733A (en) * | 1984-04-09 | 1989-10-03 | Analgesic Associates | Cough/cold mixtures comprising non-sedating antihistamine drugs |
| US4783465A (en) * | 1984-04-09 | 1988-11-08 | Analgesic Associates | Cough/cold mixtures comprising non-sedating antihistamine drugs |
| US5260073A (en) * | 1990-05-21 | 1993-11-09 | Norwich Eaton Pharmaceuticals, Inc. | Use of phenylpropanolamine as a mucus secretogogue in the upper airways |
| WO1995007103A1 (en) * | 1993-09-07 | 1995-03-16 | The Procter & Gamble Company | Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive |
| EP0841947A1 (en) * | 1995-07-28 | 1998-05-20 | The Procter & Gamble Company | Compositions containing analgesics and antihistamines and methods for treating respiratory disorders |
| US5648358A (en) * | 1996-03-05 | 1997-07-15 | Mitra; Sekhar | Compositions and methods for treating respiratory disorders |
-
1998
- 1998-08-28 KR KR1020007002958A patent/KR20010024187A/en not_active Application Discontinuation
- 1998-08-28 CA CA002304005A patent/CA2304005A1/en not_active Abandoned
- 1998-08-28 BR BR9812660-1A patent/BR9812660A/en not_active Application Discontinuation
- 1998-08-28 AU AU87443/98A patent/AU8744398A/en not_active Abandoned
- 1998-08-28 WO PCT/IB1998/001339 patent/WO1999015173A1/en not_active Application Discontinuation
- 1998-08-28 HU HU0004813A patent/HUP0004813A2/en unknown
- 1998-08-28 EP EP98938852A patent/EP1014983A1/en not_active Withdrawn
- 1998-08-28 JP JP2000512542A patent/JP2001517626A/en not_active Withdrawn
- 1998-08-28 CN CN98811202A patent/CN1278728A/en active Pending
- 1998-09-17 PE PE1998000885A patent/PE118999A1/en not_active Application Discontinuation
- 1998-09-21 CO CO98054352A patent/CO5011084A1/en unknown
-
2000
- 2000-03-17 NO NO20001412A patent/NO20001412D0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CO5011084A1 (en) | 2001-02-28 |
| WO1999015173A1 (en) | 1999-04-01 |
| KR20010024187A (en) | 2001-03-26 |
| NO20001412D0 (en) | 2000-03-17 |
| JP2001517626A (en) | 2001-10-09 |
| CN1278728A (en) | 2001-01-03 |
| BR9812660A (en) | 2000-08-22 |
| CA2304005A1 (en) | 1999-04-01 |
| PE118999A1 (en) | 2000-02-03 |
| EP1014983A1 (en) | 2000-07-05 |
| AU8744398A (en) | 1999-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0004813A2 (en) | Compositions and methods for treating respiratory disorders | |
| TW329387B (en) | Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate | |
| IS7360A (en) | Inhalation preparation | |
| EE200300514A (en) | Phthalazinones, their use in the manufacture of medicaments for the treatment of respiratory symptoms and medicinal products containing them | |
| HK1068606A1 (en) | Novel aminobenzoephenones | |
| HK1081861A1 (en) | New synergistic combination comprising roflumilast and formoterol | |
| HUP0204048A2 (en) | Use of desloratadine for treating allergic and inflammatory conditions | |
| DK1343472T3 (en) | Thixotropic nasal spray | |
| WO2002069979A3 (en) | Pharmaceutical formulation comprising r-salmeterol and fluticasone propionate | |
| ATE271852T1 (en) | IMPROVED INHALATION PREPARATIONS | |
| HK1081862A1 (en) | Synergistic combination comprising roflumilast and (r,r)-formoterol | |
| NZ505538A (en) | A vaccine comprising immunogenic acyl glyceryl phosphatidylinositol manno-oligosaccharide (PIM); and the use of PIM for inducing an immune response in a patient effective in the prevention or treatment of Th2-mediated diseases or disorders such as asthma | |
| WO2001028535A3 (en) | Pharmaceutical formulations comprising a combination of s-salmeterol and fluticasone propionate | |
| SE0102887D0 (en) | New formulation | |
| HUP0301408A2 (en) | Methods and compositions using sulodexide for the treatment of diabetic nephropathy | |
| HUP0203065A2 (en) | Use of nitric oxide for the treatment of airway constriction | |
| BR0311180A (en) | Methods for treating respiratory diseases and conditions using a selective inhibitor of inos | |
| DE60212349D1 (en) | USE OF N-ACETYL-D-GLUCOSAMINE IN THE PREPARATION OF A PHARMACEUTICAL AGENT FOR THE PREVENTION AND TREATMENT OF SEXUAL DISORDERS | |
| HUP0303822A2 (en) | Applicator for applying a benefit agent and its use | |
| WO2003045322A3 (en) | Method for treating and preventing pancreatitis | |
| IT1311903B1 (en) | FACIAL OR NASAL MASK FOR NON-INVASIVE VENTILATION OF PATIENTS IN GENERAL. | |
| ATE464051T1 (en) | COMBINATION OF LEVOSIMENDAN AND A CALCIUM SOURCE FOR THE TREATMENT OF HEART FAILURE |